Prevalence of mild cognitive impairment and its subtypes in the Mexican population
Por:
Juarez-Cedillo T., Sanchez-Arenas R., Sanchez-Garcia S., Garcia-Peña C., Hsiung G.-Y.R., Sepehry A.A., Beattie B.L., Jacova C.
Publicada:
1 ene 2013
Resumen:
Background/Aim: To estimate the prevalence of mild cognitive impairment (MCI) and its subtypes, taking into account education and health status. Methods: This is the first report of our Study on Aging and Dementia in Mexico. This study included 2,944 elderly individuals 60 years old or more with in-home assessment for cognitive impairment. The prevalence of MCI was based on Petersen criteria. MCI was classified as amnestic of single domain (a-MCI-s) or multiple domain (a-MCI-md) or nonamnestic of single domain (na-MCI-s) or multiple domain (na-MCI-md). In addition to a battery of neuropsychological measures, a self-report depression measure and a medical history including history of stroke, heart disease and other health conditions were recorded. Results: The global estimated prevalence of MCI in the Mexican population was 6.45%. Of these subjects, 2.41% met criteria for a-MCI-s, 2.56% for a-MCI-md, 1.18% for na-MCI-s and 0.30% for na-MCl-md. Women showed a higher prevalence of MCI than men (63.7 vs. 36.3%, respectively). The analysis showed that heart disease [odds ratio (OR) 1.5], stroke (OR 1.2) and depression (OR 2.1) were associated with an increased risk of MCI. Conclusions: The prevalence of MCI in Mexico is similar to that in other countries. The results suggest that stroke, heart disease and depression may have an important role in the etiology of MCI. Copyright © 2012 S. Karger AG, Basel.
Filiaciones:
Juarez-Cedillo T.:
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Area de Envejecimiento, Centro Medico Nacional Siglo XXI, Avenida Cuauhtemoc no. 330, Col. Doctores, Delegacion Cuauhtemoc, Mexico 06725, Mexico
Sanchez-Arenas R.:
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Area de Envejecimiento, Centro Medico Nacional Siglo XXI, Avenida Cuauhtemoc no. 330, Col. Doctores, Delegacion Cuauhtemoc, Mexico 06725, Mexico
Sanchez-Garcia S.:
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Area de Envejecimiento, Centro Medico Nacional Siglo XXI, Avenida Cuauhtemoc no. 330, Col. Doctores, Delegacion Cuauhtemoc, Mexico 06725, Mexico
Garcia-Peña C.:
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Area de Envejecimiento, Centro Medico Nacional Siglo XXI, Avenida Cuauhtemoc no. 330, Col. Doctores, Delegacion Cuauhtemoc, Mexico 06725, Mexico
Hsiung G.-Y.R.:
UBC Division of Neurology, Department of Medicine, Canada
UBC Hospital Clinic for Alzheimer Disease and Related Disorders, Canada
Sepehry A.A.:
UBC Division of Neurology, Department of Medicine, Canada
Beattie B.L.:
UBC Hospital Clinic for Alzheimer Disease and Related Disorders, Canada
UBC Division of Geriatric Medicine, Department of Medicine, Vancouver, BC, Canada
Jacova C.:
UBC Division of Neurology, Department of Medicine, Canada
UBC Hospital Clinic for Alzheimer Disease and Related Disorders, Canada
|